Nancy S. Hayes

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

13

H-Index

1

About

Nancy S. Hayes is a pioneering biochemist whose work has significantly advanced the field of lipid mediator assay development. Her most notable contribution is the creation of a high-capacity homogeneous fluorescent assay for leukotriene B4, a potent inflammatory mediator. This groundbreaking method, detailed in her 2005 paper (13 citations), revolutionized the measurement of leukotriene B4 by enabling rapid, sensitive, and high-throughput screening without the need for separation steps—a critical improvement over traditional techniques. Hayes’s innovation has been instrumental in accelerating research into inflammatory diseases, including asthma and arthritis, by providing researchers with a reliable tool to quantify this key biomarker. Her work exemplifies the intersection of analytical chemistry and biomedical science, offering practical solutions for complex biological challenges. While her citation count reflects the targeted impact of her research, the assay’s integration into pharmaceutical and academic laboratories underscores its enduring value. Hayes’s contributions highlight her expertise in assay design and her commitment to advancing tools that drive discovery in immunology and inflammation.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Development of a high-capacity homogeneous fluorescent assay for the measurement of leukotriene B4
13 citations · 2005
📈 Most Prolific Year: 2005 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago